Suppr超能文献

放线菌性泪小管炎:手术及短期局部抗生素治疗后的缓解。

Actinomycotic canaliculitis: resolution following surgery and short topical antibiotic treatment.

机构信息

Department of Infectious Diseases, University of Iceland Medical School, Reykjavik, Iceland.

出版信息

Acta Ophthalmol. 2010 May;88(3):367-70. doi: 10.1111/j.1755-3768.2008.01367.x. Epub 2008 Dec 13.

Abstract

PURPOSE

This study aimed to study the incidence and clinical characteristics of patients diagnosed with actinomycotic canaliculitis in Iceland.

METHODS

We present a nationwide, retrospective case series for which cases were identified by searches of hospital diagnostic registries and pathology databases. Case histories were reviewed and histopathological analysis repeated to confirm the diagnosis.

RESULTS

Nine cases of actinomycotic canaliculitis were diagnosed in Iceland during 1988-2007. Subjects included six women and three men and represented 16% of all patients diagnosed with actinomycosis in the country. The incidence was 0.16 cases/100 000 inhabitants/year. Age-specific incidence rates were 0.59 cases/100 000 inhabitants/year for the 40-59-year-old age group and 1.37 cases/100 000 inhabitants/year for individuals aged 60-79 years. All patients underwent a three-way snip procedure and 1 week of topical antibacterial therapy.

CONCLUSIONS

Actinomycotic canaliculitis is an uncommon condition which frequently eludes diagnosis. Topical antibiotics for 1 week may be sufficient following surgery, a finding which contrasts with previous reports.

摘要

目的

本研究旨在研究冰岛确诊放线菌性泪小管炎患者的发病率和临床特征。

方法

我们进行了一项全国性的回顾性病例系列研究,通过医院诊断登记处和病理数据库搜索来确定病例。对病例进行了回顾,并进行了组织病理学分析以确认诊断。

结果

1988-2007 年期间,冰岛共确诊了 9 例放线菌性泪小管炎患者。患者包括 6 名女性和 3 名男性,占该国所有放线菌病患者的 16%。发病率为 0.16 例/10 万居民/年。40-59 岁年龄组的特定年龄发病率为 0.59 例/10 万居民/年,60-79 岁年龄组的发病率为 1.37 例/10 万居民/年。所有患者均接受了三通式活检术和 1 周的局部抗菌治疗。

结论

放线菌性泪小管炎是一种罕见的疾病,常被漏诊。手术后使用 1 周的局部抗生素可能就足够了,这与之前的报告结果不同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验